Project Grant HT94252310222
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Burlington, VT 05405, USA
Similar Awards
This $2,000,000 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research on the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's disease. The award, with a performance period from June 1, 2025 to May 31, 2028, was granted to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical...
This $1,480,186 Project Grant award from the Defense Health Agency supports research by Northeast Ohio Medical University (Neomed) to model cognitive dysfunction in Parkinson's disease and the impact of exercise. The research is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for service members and the public through innovative biomedical research, including solutions for the battlefield. As the sole awardee, Neomed...
This federal Project Grant award of $1,021,409.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Illinois to investigate the underlying neurobiology of non-motor symptoms in Parkinson's disease. The research aims to elucidate the role of serotonin system plasticity in the development of these disabling non-motor complications, which can include cognitive, psychiatric, and...
The University of Toledo received a $1.7 million project grant award from the Defense Health Agency on September 15, 2021 to complete work by August 14, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Specifically, the University will investigate maladaptive nigrovagal pathophysiology in parkinsonism under this award. The research aims to...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The federal Project Grant award of $200,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by Northwestern University to elucidate the neural basis of hallucinations in Parkinson's disease. The award, effective July 1, 2025 through June 30, 2027, will enable Northwestern University's researchers to investigate this critical medical challenge and develop innovative solutions to transform healthcare for military...
The U.S. Department of the Army Medical Command awarded a $494,774 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Aarhus Universitet, a Danish educational institution, to develop nonmotor biomarkers to diagnose Parkinson's disease subtypes early on. The award, which runs from December 15, 2024 to December 14, 2026, will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader...
The Defense Health Agency awarded a $199,966 project grant to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used to conduct research on the foundations supporting neuroprosthetic management of hypotensive complications in...
This Project Grant award of $1,022,173 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Virginia Polytechnic Institute & State University (Virginia Tech) to investigate the role of traumatic brain injury in the progression of Parkinson's disease. The award period runs from April 15, 2025 to April 14, 2028. Virginia Tech, a leading public research university, will leverage its extensive...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,047,751 Project Grant to the Portland VA Research Foundation, Inc. to conduct the "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE" research project. This 4-year award, beginning on Sep 1, 2024 and ending on Aug 31, 2028, will enable the Portland VA Research Foundation to carry out scientific research aimed at improving health outcomes for...